Search Results - "Shankar, Gopi"

Refine Results
  1. 1

    A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum by Ehlinger, Christopher, Spear, Nathan, Doddareddy, Rajitha, Shankar, Gopi, Schantz, Allen

    Published in Journal of immunological methods (01-11-2019)
    “…Detection of anti-drug antibodies is a critical step in the development of large molecule biopharmaceuticals. In the case of multicomponent/multifunctional…”
    Get full text
    Journal Article
  2. 2

    A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs by Shankar, Gopi, Pendley, Charles, Stein, Kathryn E

    Published in Nature biotechnology (01-05-2007)
    “…Bioanalytical assessments of anti-drug antibodies (ADAs) provide an understanding of the immunogenicity of biological drug molecules. The potential to induce…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet ® biolayer interferometry by Li, Jian, Schantz, Allen, Schwegler, Maureen, Shankar, Gopi

    “…We assessed the utility of the FortéBio Octet ® system for detection of anti-drug antibodies (ADAs) against an investigational therapeutic human IgG1…”
    Get full text
    Journal Article
  5. 5

    Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab by Benson, Jacqueline M, Sachs, Clifford W, Treacy, George, Zhou, Honghui, Pendley, Charles E, Brodmerkel, Carrie M, Shankar, Gopi, Mascelli, Mary A

    Published in Nature biotechnology (01-07-2011)
    “…Preclinical and clinical studies conducted in the mid-1990s reported strong association and causality between the T-cell helper (T H ) 1 inductor cytokine…”
    Get full text
    Journal Article
  6. 6

    Role of bronchoscopy and imaging in long-standing foreign body bronchus presenting as recurrent or non-resolving lower respiratory tract infection by Agrawal, Shailesh Ramesh, Gopi Shankar, S., Joshi, Anagha A., Patekar, Shivali, Bradoo, Renuka A.

    Published in European archives of oto-rhino-laryngology (01-05-2021)
    “…Introduction A long-standing retained foreign body in the bronchus is unusual. In majority of cases, an adequate history is not obtained, the clinical picture…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    “AIR LEAK SYNDROME”: An Unusual Presentation of Foreign Body in the Airway by Velecharla, Madhu Sudhan, Shah, Kshitij Dhaval, Bradoo, Renuka Anil, Subramaniasami, Gopi Shankar, Joshi, Anagha Atul

    “…Spontaneous onset pneumomediastinum, pneumothorax and subcutaneous emphysema are rare presentations of a foreign body in the airway. The possible mechanism for…”
    Get full text
    Journal Article
  10. 10

    Tetraselmis indica Mediated Green Synthesis of Zinc Oxide (ZnO) Nanoparticles and Evaluating Its Antibacterial, Antioxidant, and Hemolytic Activity by Thirumoorthy, Gopi Shankar, Balasubramaniam, Oviyashri, Kumaresan, Punitha, Muthusamy, Poongothai, Subramani, Karthik

    Published in BioNanoScience (01-03-2021)
    “…The indenture of the green approach in synthesizing metal oxide nanoparticles has resulted in greater stoutness and favorable dimensions of nanoparticles since…”
    Get full text
    Journal Article
  11. 11

    Lack of Racial Differences in the Pharmacokinetics of Subcutaneous Golimumab in Healthy Japanese and Caucasian Male Subjects by Ling, Jie, Lyn, Sally, Xu, Zhenhua, Achira, Meguru, Bouman-Thio, Esther, Shishido, Akira, Ford, Joyce, Shankar, Gopi, Wagner, Carrie, Kim, Kenneth T., Davis, Hugh M., Zhou, Honghui

    Published in Journal of clinical pharmacology (01-07-2010)
    “…This phase 1 study evaluated the single‐dose pharmacokinetics and safety of subcutaneous golimumab, a human anti—tumor necrosis factor‐α monoclonal antibody,…”
    Get full text
    Journal Article
  12. 12

    Current challenges in assessing immunogenicity by Shankar, Gopi

    Published in Bioanalysis (01-09-2019)
    “…Gopi Shankar is a Vice President at Janssen BioTherapeutics, the biotechnology discovery and development unit of Janssen Research & Development, LLC (one of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis by Shankar, Gopi, Cohen, Donald A.

    “…Pulmonary complications and graft‐vs.‐host disease (GVHD) remain severe threats to survival after bone marrow transplantation (BMT). Idiopathic pneumonia…”
    Get full text
    Journal Article
  15. 15

    Interferon-gamma Added During Bacillus Calmette-Guerin Induced Dendritic Cell Maturation Stimulates Potent Th1 Immune Responses by Shankar, Gopi, Pestano, Linda A, Bosch, Marnix L

    Published in Journal of translational medicine (10-10-2003)
    “…Dendritic cells (DC) are increasingly prepared in vitro for use in immunotherapy trials. Mature DC express high levels of surface molecules needed for T cell…”
    Get full text
    Journal Article
  16. 16

    Immunogenicity of golimumab and its clinical relevance in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis by Leu, Jocelyn H, Adedokun, Omoniyi J, Gargano, Cynthia, Hsia, Elizabeth C, Xu, Zhenhua, Shankar, Gopi

    Published in Rheumatology (Oxford, England) (01-03-2019)
    “…Abstract Objective Golimumab immunogenicity was extensively studied during clinical development. As anti-drug antibody (ADA) detection with the standard…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The challenge of indication extrapolation for infliximab biosimilars by Feagan, Brian G., Choquette, Denis, Ghosh, Subrata, Gladman, Dafna D., Ho, Vincent, Meibohm, Bernd, Zou, Guangyong, Xu, Zhenhua, Shankar, Gopi, Sealey, David C., Russell, Anthony S.

    Published in Biologicals (01-07-2014)
    “…A biosimilar is intended to be highly similar to a reference biologic such that any differences in quality attributes (i.e., molecular characteristics) do not…”
    Get full text
    Journal Article
  19. 19

    P049 COMPARISON OF USTEKINUMAB CONCENTRATION ASSAYS AND ANTIBODIES-TO-USTEKINUMAB ASSAYS by Marini, Joseph C, Chun, Kelly Y, Rebarchak, Shannon, Dogmanits, Shannon, Sloan, Sheldon, Shankar, Gopi

    Published in Inflammatory bowel diseases (07-02-2019)
    “…Abstract Background Monitoring ustekinumab (UST) concentrations and antibodies-to ustekinumab (ATU) during IBD treatment may allow more informed decisions in…”
    Get full text
    Journal Article
  20. 20

    Development of a Method That Eliminates False-Positive Results due to Nerve Growth Factor Interference in the Assessment of Fulranumab Immunogenicity by Dai, Sheng, Schantz, Allen, Clements-Egan, Adrienne, Cannon, Michael, Shankar, Gopi

    Published in The AAPS journal (01-05-2014)
    “…Fulranumab, a human IgG2 monoclonal antibody that neutralizes nerve growth factor (NGF), is currently in development for the treatment of pain. Our initial…”
    Get full text
    Journal Article